Vimarsana
Biggest News Aggregation in the World

Page 14 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

'Inspections Resembling Raids': RSS Affiliate Urges Centre to Overlook 'Minor Lapses' in Pharma Firms - Vimarsana News

'Inspections Resembling Raids': RSS Affiliate Urges Centre to Overlook 'Minor Lapses' in Pharma Firms

Laghu Udyog Bharati has clarified that the industry needs a “minimum three-year period” to upgrade itself to Schedule M or WHO-GMP standards, calling the government’s deadline of six months to one year “impractical”

Source: news18.com
OTC Stocks Under A Penny Watchlist (ATVK, GSTC, YCRM, IMTL) - Ameritek Ventures (OTC:ATVK), GlobeStar Therapeutics (OTC:GSTC) - Vimarsana News

OTC Stocks Under A Penny Watchlist (ATVK, GSTC, YCRM, IMTL) - Ameritek Ventures (OTC:ATVK), GlobeStar Therapeutics (OTC:GSTC)

In the world of OTC penny stocks, four that trading under a penny have recently commanded attention with their recent developments. These low-cost stocks offer potential opportunities for investors. Examining their

Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare ... - Vimarsana News

Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare ...

Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare ...

Amid Complaints Over Made-in-India Medicines, Govt Rolls Out Workshops to Handhold MSME Drugmakers - Vimarsana News

Amid Complaints Over Made-in-India Medicines, Govt Rolls Out Workshops to Handhold MSME Drugmakers

With small and medium-sized pharmaceutical companies facing increased scrutiny from global regulators due to recurring lapses, the Narendra Modi government is planning to handhold these drugmakers.

Source: news18.com
pharma: DCGI initiates review of pharma manufacturing standards to ensure drug quality and safety - Vimarsana News

pharma: DCGI initiates review of pharma manufacturing standards to ensure drug quality and safety

India's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ensure the quality, safety, and efficacy of drugs. The DCGI will meet with pharma industry associations to discuss reviewing Good Manufacturing Practices (GMP) for pharma companies. The government aims to upgrade Schedule M, which lays down GMP, to international standards.